• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从一名63岁迟发性阿尔茨海默病(LOAD)患者建立诱导多能干细胞(iPSC)系。

Establishment of induced pluripotent stem cell (iPSC) line from a 63-year old patient with late onset Alzheimer's disease (LOAD).

作者信息

Chandrasekaran Abinaya, Varga Eszter, Nemes Csilla, Táncos Zsuzsanna, Kobolák Julianna, Dinnyés András

机构信息

BioTalentum Ltd., Gödöllő, Hungary.

BioTalentum Ltd., Gödöllő, Hungary; Molecular Animal Biotechnology Laboratory, Szent István University, Gödöllő, Hungary.

出版信息

Stem Cell Res. 2016 Jul;17(1):78-80. doi: 10.1016/j.scr.2016.05.014. Epub 2016 May 24.

DOI:10.1016/j.scr.2016.05.014
PMID:27558607
Abstract

Peripheral blood mononuclear cells (PBMCs) were collected from a clinically characterised 63-year old woman with late onset Alzheimer's disease (LOAD). The PMBCs were reprogrammed with the human OSKM transcription factors using the Sendai-virus delivery system. The transgene-free iPSC showed pluripotency verified by immunocytochemistry for pluripotency markers and differentiated spontaneously towards the 3 germ layers in vitro. Furthermore, the iPSC line showed normal karyotype. Our model might offer a good platform to further study the pathomechanism of sporadic AD, to identify early biomarkers and also for drug testing and gene therapy studies.

摘要

从一名临床诊断为迟发性阿尔茨海默病(LOAD)的63岁女性患者身上采集外周血单核细胞(PBMCs)。使用仙台病毒递送系统,用人OSKM转录因子对PBMCs进行重编程。通过免疫细胞化学检测多能性标志物,证实无转基因的诱导多能干细胞(iPSC)具有多能性,并在体外自发分化为三个胚层。此外,该iPSC系显示出正常的核型。我们的模型可能为进一步研究散发性阿尔茨海默病的发病机制、识别早期生物标志物以及进行药物测试和基因治疗研究提供一个良好的平台。

相似文献

1
Establishment of induced pluripotent stem cell (iPSC) line from a 63-year old patient with late onset Alzheimer's disease (LOAD).从一名63岁迟发性阿尔茨海默病(LOAD)患者建立诱导多能干细胞(iPSC)系。
Stem Cell Res. 2016 Jul;17(1):78-80. doi: 10.1016/j.scr.2016.05.014. Epub 2016 May 24.
2
Establishment of induced pluripotent stem cell (iPSC) line from a 75-year old patient with late onset Alzheimer's disease (LOAD).从一名75岁迟发性阿尔茨海默病(LOAD)患者建立诱导多能干细胞(iPSC)系。
Stem Cell Res. 2016 Jul;17(1):81-83. doi: 10.1016/j.scr.2016.05.013. Epub 2016 May 24.
3
Establishment of induced pluripotent stem cell (iPSC) line from an 84-year old patient with late onset Alzheimer's disease (LOAD).从一名84岁迟发性阿尔茨海默病(LOAD)患者建立诱导多能干细胞(iPSC)系。
Stem Cell Res. 2016 Jul;17(1):75-77. doi: 10.1016/j.scr.2016.05.016. Epub 2016 May 24.
4
Establishment of induced pluripotent stem cell (iPSC) line from a 57-year old patient with sporadic Alzheimer's disease.从一名57岁散发性阿尔茨海默病患者建立诱导多能干细胞(iPSC)系。
Stem Cell Res. 2016 Jul;17(1):72-74. doi: 10.1016/j.scr.2016.05.020. Epub 2016 May 25.
5
Establishment of an induced pluripotent stem cell (iPSC) line from a 9-year old male with autism spectrum disorder (ASD).从一名9岁患自闭症谱系障碍(ASD)的男性身上建立诱导多能干细胞(iPSC)系。
Stem Cell Res. 2017 May;21:19-22. doi: 10.1016/j.scr.2017.03.013. Epub 2017 Mar 18.
6
Characterization of human induced pluripotent stem cell (iPSC) line from a 72year old male patient with later onset Alzheimer's disease.源自一名72岁晚发性阿尔茨海默病男性患者的人诱导多能干细胞(iPSC)系的特征分析
Stem Cell Res. 2017 Mar;19:34-36. doi: 10.1016/j.scr.2016.12.024. Epub 2016 Dec 23.
7
Establishment of EHMT1 mutant induced pluripotent stem cell (iPSC) line from a 11-year-old Kleefstra syndrome (KS) patient with autism and normal intellectual performance.从一名患有自闭症但智力正常的11岁克莱夫斯特拉综合征(KS)患者建立EHMT1突变诱导多能干细胞(iPSC)系。
Stem Cell Res. 2016 Nov;17(3):531-533. doi: 10.1016/j.scr.2016.09.031. Epub 2016 Oct 2.
8
Establishment of TUSMi008-A, an induced pluripotent stem cell (iPSC) line from a 76-year old Alzheimer's disease (AD) patient with PAXIP1 gene mutation.TUSMi008-A的建立,这是一株来自一名患有PAXIP1基因突变的76岁阿尔茨海默病(AD)患者的诱导多能干细胞(iPSC)系。
Stem Cell Res. 2019 Apr;36:101391. doi: 10.1016/j.scr.2019.101391. Epub 2019 Jan 26.
9
Establishment of TUSMi007-A, an induced pluripotent stem cell (iPSC) line from an 83-year old Chinese Han patient with Alzheimer's disease (AD).TUSMi007-A的建立,这是一株源自一名83岁患有阿尔茨海默病(AD)的中国汉族患者的诱导多能干细胞(iPSC)系。
Stem Cell Res. 2018 Dec;33:265-268. doi: 10.1016/j.scr.2018.11.008. Epub 2018 Nov 28.
10
Derivation of human induced pluripotent stem cell (iPSC) line from a 79year old sporadic male Parkinson's disease patient.从一名79岁散发性男性帕金森病患者身上获得人诱导多能干细胞(iPSC)系。
Stem Cell Res. 2017 Mar;19:43-45. doi: 10.1016/j.scr.2016.12.025. Epub 2016 Dec 20.

引用本文的文献

1
The occurrence and development of induced pluripotent stem cells.诱导多能干细胞的发生与发展。
Front Genet. 2024 Apr 18;15:1389558. doi: 10.3389/fgene.2024.1389558. eCollection 2024.
2
Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.源自散发性阿尔茨海默病 iPSC 的神经元显示出 TAU 过度磷酸化增加、淀粉样蛋白水平升高和 GSK3β 激活。
Alzheimers Res Ther. 2017 Dec 1;9(1):90. doi: 10.1186/s13195-017-0317-z.
3
3D culture models of Alzheimer's disease: a road map to a "cure-in-a-dish".
阿尔茨海默病的3D培养模型:“盘中治愈”之路。
Mol Neurodegener. 2016 Dec 9;11(1):75. doi: 10.1186/s13024-016-0139-7.
4
Blood Derived Induced Pluripotent Stem Cells (iPSCs): Benefits, Challenges and the Road Ahead.血液来源的诱导多能干细胞(iPSCs):益处、挑战与未来之路。
J Alzheimers Dis Parkinsonism. 2016 Oct;6(5). doi: 10.4172/2161-0460.1000275. Epub 2016 Oct 25.